Johnson Chemical Pharmaceutical Works Co., Ltd. (4747.TWO)
TWD 70.7
(-3.42%)
TWD 70.7
(-3.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 136.95 Million | 89.68 Million | 52.34 Million | 71.77 Million | - |
| Net Income | 100.88 Million | 81.53 Million | 61.93 Million | 76.55 Million | - |
| Depreciation & Amortization | 21.1 Million | 18.26 Million | 15.28 Million | 13.23 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 6.37 Million | - | - | - | - |
| Change in working capital | 21.7 Million | 2.26 Million | -17.02 Million | -2.14 Million | - |
| Other non-cash items | -1.73 Million | 568 Thousand | 507 Thousand | -193 Thousand | - |
| Investing Cash Flow | -33.27 Million | -59.92 Million | -38.14 Million | -161.61 Million | - |
| Investments in PPE | -33.11 Million | -59.7 Million | -37.28 Million | -162.18 Million | - |
| Acquisitions | 5000.00 | - | - | - | -6.93 Million |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -169 Thousand | -214 Thousand | -857 Thousand | -60 Thousand | - |
| Financing Cash Flow | 815.46 Million | -63.52 Million | -107.63 Million | 75.96 Million | - |
| Debt repayment | -395.35 Million | -20 Million | -50 Million | -130 Million | - |
| Dividends payments | -60.03 Million | -43.52 Million | -57.63 Million | -54.03 Million | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 480 Million | - | - | - | - |
| Other Financing Activities | 150 Thousand | - | - | - | - |
| Accounts receivables | -10.21 Million | - | - | - | - |
| Accounts payables | 34.5 Million | - | - | - | - |
| Inventory | -11.77 Million | 19.44 Million | 11.44 Million | -24.47 Million | - |
| Other working capital | 43.69 Million | - | - | - | - |
| Cash at beginning of period | 168.47 Million | 202.23 Million | 295.66 Million | 309.53 Million | - |
| Cash at end of period | 1.08 Billion | 168.47 Million | 202.23 Million | 295.66 Million | - |
| Capital Expenditure | -33.11 Million | -59.7 Million | -37.28 Million | -162.18 Million | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 919.13 Million | -33.76 Million | -93.43 Million | -13.87 Million | - |
| Free Cash Flow | 103.83 Million | 29.97 Million | 15.05 Million | -90.4 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 27.81 Million | 25.7 Million | 100.88 Million | 22.27 Million | 22.04 Million | 28.47 Million |
| Depreciation & Amortization | 5.22 Million | 5.38 Million | 21.1 Million | 5.53 Million | 5.21 Million | 5.21 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 6.37 Million | - | - | - |
| Change in working capital | 1.07 Million | -15.61 Million | 21.7 Million | 9.32 Million | 18.8 Million | -2.81 Million |
| Other non-cash items | -3.02 Million | -1.33 Million | -1.73 Million | -3.4 Million | 1.48 Million | -18 Thousand |
| Investing Cash Flow | -6.33 Million | -3.58 Million | -33.27 Million | -13.58 Million | -6.39 Million | -5.47 Million |
| Investments in PPE | -6.7 Million | -3.41 Million | -33.11 Million | -13.43 Million | -6.37 Million | -5.47 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 365 Thousand | -175 Thousand | -169 Thousand | -150 Thousand | -20 Thousand | - |
| Financing Cash Flow | 286 Thousand | - | 815.46 Million | - | 396.98 Million | 418.48 Million |
| Debt repayment | -286 Thousand | - | -395.35 Million | - | - | -395.35 Million |
| Dividends payments | - | - | -60.03 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 480 Million | - | 456.86 Million | - |
| Other Financing Activities | - | - | 150 Thousand | - | - | - |
| Accounts receivables | -3.21 Million | - | - | - | - | - |
| Accounts payables | 9.61 Million | - | - | - | - | - |
| Inventory | -8.78 Million | 16.08 Million | -11.77 Million | -5.88 Million | -5.75 Million | -12.7 Million |
| Other working capital | 2.23 Million | - | - | - | - | - |
| Cash at beginning of period | 1.1 Billion | 1.08 Billion | 168.47 Million | 1.06 Billion | 624.2 Million | 190.27 Million |
| Cash at end of period | 1.1 Billion | 1.1 Billion | 1.08 Billion | 1.08 Billion | 1.06 Billion | 624.2 Million |
| Capital Expenditure | -6.7 Million | -3.41 Million | -33.11 Million | -13.43 Million | -6.37 Million | -5.47 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 7.56 Million | 12.64 Million | 919.13 Million | 24.59 Million | 438.81 Million | 433.93 Million |
| Free Cash Flow | 7.19 Million | 12.81 Million | 103.83 Million | 24.74 Million | 41.85 Million | 15.44 Million |
THRY
4124
SWP
SBFC
PHP
INCF